Regulatory updateRetina
Faricimab: start with the current EU product information
EMA · Regulatory sourceEuropean Medicines Agency ↗
Editorial review: not recorded.
Bottom line
The EMA Vabysmo record is the authoritative entry point for EU product information, assessment documents and authorised indications.
Why read it
Keep drug evidence and jurisdiction-specific product information linked in one place.
What this does not prove
Source checked on 2026-09-17; no new approval is asserted. Consult the current product information for prescribing.
Original source
Source date: 17 Sept 2026 · EU
Report a correction →